Nanobac Pharmaceuticals Inc NNBP:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/04/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date04/25/23
  • 52 Week Low0.00
  • 52 Week Low Date04/04/24

Key Stats

  • Market Cap249.507
  • Shares Out249.51M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date04/25/23
  • 52 Week Low0.00
  • 52 Week Low Date04/04/24
  • Market Cap249.507
  • Shares Out249.51M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.454M
  • ROE (TTM)-
  • Revenue (TTM)17,999.999
  • Gross Margin (TTM)16.67%
  • Net Margin (TTM)-36,527.78%
  • Debt To Equity (MRQ)-174.51%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nanobac Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nanobac Pharmaceuticals, Incorporated (Nanobac) is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve people’s health through the detection and treatment of Calcifying Nanoparticles (CNPs), otherwise known as nanobacteria. Its research is directed toward establishing the pathogenic role of nanobacteria in soft tissue calcification, particularly in coronary artery heart disease...
John Stanton
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Address
5025 W Lemon St
Tampa, FL
33609-1101
United States